| Company Name: |
PHARMEKS Ltd.
|
| Tel: |
+7 (495) 702-9648 |
| Email: |
sales@pharmeks.com |
| Products Intro: |
CAS:1214043-29-4
Package:5μmol Remarks:C19H18ClN3O3
|
|
| | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Basic information |
| Product Name: | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide | | Synonyms: | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide;1H-1,4-Benzodiazepine-3-propanamide, N-[(3-chlorophenyl)methyl]-2,3,4,5-tetrahydro-2,5-dioxo- | | CAS: | 1214043-29-4 | | MF: | C19H18ClN3O3 | | MW: | 371.82 | | EINECS: | | | Product Categories: | | | Mol File: | 1214043-29-4.mol | ![N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Structure](CAS/20180723/GIF/1214043-29-4.gif) |
| | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Chemical Properties |
| Boiling point | 754.6±60.0 °C(Predicted) | | density | 1.289±0.06 g/cm3(Predicted) | | pka | 12.69±0.40(Predicted) |
| | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Usage And Synthesis |
| | N-[(3-chlorophenyl)methyl]-3-(2,5-dioxo-3,4-dihydro-1H-1,4-benzodiazepin-3-yl)propanamide Preparation Products And Raw materials |
|